Tech Company Financing Transactions

Tryton Medical Funding Round

PTV Sciences, RiverVest Venture Partners and Spray Venture Partners joined a $14 million Series C capital raise for Tryton Medical. The round closed on 3/31/2008.

Transaction Overview

Company Name
Announced On
3/31/2008
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series C
Investors

PTV Sciences (Rick Anderson)

RiverVest Venture Partners (Jay Schmelter)

Spray Venture Partners (Daniel Cole)

Proceeds Purpose
Dan Cole, Co-Founder and Board Member of Tryton and General Partner of Spray Venture Partners said, "This capital will allow Tryton to advance its leadership position with aggressive execution of its European commercialization strategy and clinical trial plans in the U.S."

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1000 Park Forty Plaza 325
Durham, NC 27713
USA
Email Address
Overview
Tryton Medical, Inc. is the leading developer of stents that are designed to definitively treat bifurcation lesions. 540,000 bifurcation coronary lesions are sub-optimally treated every year with a variety of time consuming and technically challenging procedures.
Profile
Tryton Medical LinkedIn Company Profile
Social Media
Tryton Medical Company Twitter Account
Company News
Tryton Medical News
Facebook
Tryton Medical on Facebook
YouTube
Tryton Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Carl Bernard
  Carl Bernard LinkedIn Profile  Carl Bernard Twitter Account  Carl Bernard News  Carl Bernard on Facebook
Chief Financial Officer
Brett Farabaugh
  Brett Farabaugh LinkedIn Profile  Brett Farabaugh Twitter Account  Brett Farabaugh News  Brett Farabaugh on Facebook
Chief Medical Officer
Aaron Kaplan
  Aaron Kaplan LinkedIn Profile  Aaron Kaplan Twitter Account  Aaron Kaplan News  Aaron Kaplan on Facebook
Chief Operating Officer
Richard Davis
  Richard Davis LinkedIn Profile  Richard Davis Twitter Account  Richard Davis News  Richard Davis on Facebook
VP - Regulatory Affairs
Douglas Ferguson
  Douglas Ferguson LinkedIn Profile  Douglas Ferguson Twitter Account  Douglas Ferguson News  Douglas Ferguson on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2008: Estorian venture capital transaction
Next: 3/31/2008: Articulinx venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary